BSE Live
Mar 10, 11:58Prev. Close
4772.55
Open Price
4785.50
Bid Price (Qty.)
4800.70 (3)
Offer Price (Qty.)
4808.50 (5)
NSE Live
Mar 10, 11:58Prev. Close
4769.50
Open Price
4803.50
Bid Price (Qty.)
4803.50 (1)
Offer Price (Qty.)
4806.00 (2)
| Balance Sheet of Pfizer (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 16 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 45.75 | 29.84 | 29.84 | 29.84 | 29.84 | |
| Total Share Capital | 45.75 | 29.84 | 29.84 | 29.84 | 29.84 | |
| Reserves and Surplus | 1,927.26 | 628.57 | 1,664.58 | 1,274.85 | 1,133.60 | |
| Total Reserves and Surplus | 1,927.26 | 628.57 | 1,664.58 | 1,274.85 | 1,133.60 | |
| Total Shareholders Funds | 1,973.01 | 658.41 | 1,694.42 | 1,304.70 | 1,163.45 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 2.50 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 0.10 | 0.10 | 0.10 | 0.00 | 6.38 | |
| Long Term Provisions | 29.56 | 15.55 | 14.07 | 25.83 | 28.20 | |
| Total Non-Current Liabilities | 32.17 | 15.65 | 14.17 | 25.83 | 34.58 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 334.20 | 159.93 | 150.59 | 130.93 | 98.03 | |
| Other Current Liabilities | 86.60 | 54.68 | 39.56 | 35.64 | 42.78 | |
| Short Term Provisions | 185.56 | 35.67 | 160.76 | 79.36 | 47.42 | |
| Total Current Liabilities | 606.37 | 250.28 | 350.91 | 245.93 | 188.23 | |
| Total Capital And Liabilities | 2,611.55 | 924.35 | 2,059.50 | 1,576.45 | 1,386.25 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 75.09 | 20.02 | 24.84 | 30.67 | 35.01 | |
| Intangible Assets | 869.25 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 12.56 | 3.16 | 0.37 | 0.70 | 1.64 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 956.90 | 23.90 | 25.94 | 32.25 | 37.53 | |
| Non-Current Investments | 42.66 | 44.49 | 45.99 | 47.44 | 48.95 | |
| Deferred Tax Assets [Net] | 67.14 | 34.19 | 39.88 | 37.08 | 35.54 | |
| Long Term Loans And Advances | 291.56 | 136.54 | 143.31 | 128.88 | 92.72 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 1,358.26 | 239.12 | 255.11 | 245.65 | 214.74 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | |
| Inventories | 387.90 | 151.50 | 165.15 | 183.24 | 159.32 | |
| Trade Receivables | 157.87 | 173.39 | 142.09 | 141.78 | 100.17 | |
| Cash And Cash Equivalents | 609.29 | 307.79 | 1,432.94 | 866.27 | 578.46 | |
| Short Term Loans And Advances | 83.93 | 47.17 | 43.23 | 129.83 | 325.23 | |
| OtherCurrentAssets | 14.30 | 5.38 | 20.98 | 9.64 | 8.33 | |
| Total Current Assets | 1,253.28 | 685.23 | 1,804.39 | 1,330.80 | 1,171.51 | |
| Total Assets | 2,611.55 | 924.35 | 2,059.50 | 1,576.45 | 1,386.25 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 454.58 | 372.46 | 411.80 | 349.90 | 347.27 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 139.23 | 72.46 | 68.75 | 57.65 | 56.97 | |
| Stores, Spares And Loose Tools | 288.15 | 32.54 | 24.41 | 45.34 | 32.30 | |
| Trade/Other Goods | 288.15 | 32.54 | 24.41 | 45.34 | 32.30 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 10.95 | 9.37 | 6.94 | 4.51 | 5.47 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | 828.69 | 26.39 | 8.45 | 52.78 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 0.93 | 0.50 | 1.24 | 1.71 | 1.90 | |
| Other Earnings | 10.76 | 7.78 | 14.27 | 20.39 | 36.21 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 19.11 | 19.11 | 19.11 | 19.11 | 19.11 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 42.66 | 44.49 | 45.99 | 47.44 | 48.95 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | 0.05 | -- |
10.02.2026
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011